As Insurers Drop GLP-1 Coverage, Advocates Search for a Hero in Obesity
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for treating obesity.
What Full-Circle EMS–Hospital Interoperability Looks Like in Practice
From field documentation to post-discharge outcomes, interoperability isn’t a future ideal — it’s a present necessity. Here’s what seamless EMS–hospital data exchange looks like, and why it matters now.
AI-Based Simulation Training is Key to Solving Dentistry’s Procedural Skills Crisis
Giving dentists more hands-on training provides a platform for repeated practice, real-time feedback, and continuous improvement, helping prepare students with the confidence and consistency they need to succeed in patient care.
BMS Joins the In Vivo Cell Therapy Chase With $1.5B Orbital Therapeutics Acquisition
Startup Orbital Therapeutics brings Bristol Myers Squibb an in vivo cell therapy in development for treating autoimmune disease. With the deal, BMS joins AstraZeneca, AbbVie, and Gilead Sciences in turning to M&A as a way to get in vivo cell therapy assets and technologies.